<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-80661</identifier>
<setSpec>0211-139X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Recomendations for the prevention of adverse drug reactions in older adults with dementia</dc:title>
<dc:description xml:lang="en">The elderly are one of the groups at greatest risk for adverse drugs reactions (ADR). The mean prevalence of these reactions in this population is 30%. Dementia is not an independent risk factor of ADR, but is the main condition that increases all risk factors (polypharmacy, comorbidity, inappropriate prescribing, drug&#150;drug interactions, advanced age, and treatment adherence). The present article discusses revised and consensual recommendations for the prevention of ADR in the elderly, as well as recommendations specifically for dementia patients in relation to the management of comorbidity and cognitive, behavioral and psychological symptoms(AU)</dc:description>
<dc:creator>Jiménez Páez, José Máría</dc:creator>
<dc:creator>Gómez-Pavón, Javier</dc:creator>
<dc:creator>González García, Paloma</dc:creator>
<dc:creator>Vidán Astiz, Maite</dc:creator>
<dc:creator>Gutiérrez Rodríguez, José</dc:creator>
<dc:creator>Francés Román, Inés</dc:creator>
<dc:creator>Álvarez Fernández, Baldomero</dc:creator>
<dc:creator>Montero Fernández, Nuria Pilar</dc:creator>
<dc:creator>Jiménez Díaz, Gregorio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las personas mayores son uno de los grupos poblacionales de mayor riesgo de reacción adversa a medicamentos (RAM). Su prevalencia media en el anciano es del 30%. La demencia no es un factor de riesgo independiente de RAM pero, sin embargo, es la principal situación que favorece y multiplica todos los factores de riesgo (polifarmacia, comorbilidad, prescripción inadecuada, interacción medicamentosa, edad avanzada y adherencia terapéutica). Se exponen recomendaciones revisadas y consensuadas para prevenir las RAM en las personas mayores, a la vez que las propias de las personas con demencia en relación con el manejo de la comorbilidad y de los síntomas cognitivos, psicológicos y conductuales(AU)</dc:description>
<dc:source>Rev. esp. geriatr. gerontol. (Ed. impr.);45(2): 89-96, mar.-abr.2010. ttab, ilus</dc:source>
<dc:identifier>ibc-80661</dc:identifier>
<dc:title xml:lang="es">Recomendaciones en la prevención de reacciones adversas a medicamentos en personas mayores con demencia</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d^s22054</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d33105</dc:subject>
<dc:subject>^d^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3718^s22012</dc:subject>
<dc:subject>^d23106^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:type>article</dc:type>
<dc:date>201004</dc:date>
</metadata>
</record>
</ibecs-document>
